Axol Bioscience is the leading provider of product and service solutions within the induced pluripotent stem cell (iPSC)-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets. Our custom research capabilities in gene editing, electrophysiology, reprogramming, and differentiation means we can offer customers validated ready-to-use cell lines and a suite of services bolstered by deep scientific expertise and robust functional data - all with short lead times.